MedTrace Logo

Safety and Clinical Performance of a Sirolimus-eluting Absorbable Metal Scaffold

NCT02916485 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2017-06-14

No results posted yet for this study

Summary

Assessment of the clinical performance and the safety of the Magmaris Sirolimus-Eluting Resorbable Coronary Magnesium Scaffold in a cohort of patients in India with de novo coronary artery lesions.

Conditions

Interventions

DEVICE

Bioresorbable scaffold

Percutaneous coronary intervention (PCI)

Sponsors & Collaborators

  • CBCC-VIBGYOR Research Pvt. Ltd.

    collaborator OTHER

  • Biotronik AG

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-30
Primary Completion
2018-02-28
Completion
2018-09-30

Countries

  • India

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02916485 on ClinicalTrials.gov